SEARCH OUR PRODUCT CATALOG

Company News

Empire Genomics Partners With KromaTiD to Offer More Robust Solutions for Detecting Oncology Abnormalities
Empire Genomics announced today that it has entered into a new strategic partnership with KromaTiD to provide a comprehensive offering to better understand the genomic abnormalities of cancer patients.
Read More
Understand Your Genome
Empire Genomics CEO Anthony Johnson will be speaking at the Understand Your Genome conference today in Boston about the need for increased diversity in humans being sequenced. Understand Your Genome (UYG) provides a unique, hands-on opportunity to learn about the information encoded within your own genome. This educational symposium is designed to engage individuals to learn about the untapped potential of DNA to improve health care and management. It is a dynamic community of individuals who are paving the way for precision medicine, and a new standard of care.
Read More
Empire Genomics building a global network
The Buffalo-based global molecular diagnostics company, which specializes in oncology products and clinical services, sells and ships directly to customers worldwide. Distributors provide detailed knowledge of local dynamics and logistics needs. The company now has distributors that span 29 companies in 23 countries.
Read More
Buffalo's new STEM high school program will enroll 40 students this fall; future sites considered
About 40 incoming freshman in the Buffalo City School District have signed up for a new high-school program that will aim to prepare them for a career in a STEM field.
Read More
Empire Genomics CEO Selected Fellow as Health Care Innovator for Aspen Institute
Anthony Johnson, Empire Genomics Chief Executive Officer and President, is one of twenty-one health care leaders selected to participate in the Aspen Institute’s Health Care Innovators Fellowship Program.
Read More
Play Golf & Make A Difference In Local Students' Futures In Science
Empire Genomics is hosting an Inaugural Golf Benefit, Tee it Up for STEM, which will be funding scholarships awarded to local students pursuing college careers in Science, Technology, Engineering, and Math (STEM).
Read More
Empire Genomics Gains $1.75M in Venture Capital
Empire Genomics has closed a $1.75 million follow-on financing round, the company and investor Rand Capital said yesterday.
Read More
New York State Grants Clinical Lab Permit to Empire Genomics
Cancer diagnostics company Empire Genomics announced today that it has received approval from New York State to offer molecular and cellular tumor marker testing through the state's Clinical Laboratory Evaluation Program (CLEP).
Read More
Orchard Park High School Honors Empire Genomics!
Empire Genomics, an active member of their local community, participated in Orchard Park High School's annual Career Shadow Day Program. Students toured the facility, met skilled scientists and staff members, and immersed themselves in a hands on experience inside Empire's diagnostics lab. Orchard Park High School thanked Empire with a Certificate of Acknowledgement!
Read More
Empire Genomics Partners with Buffalo's Research Laboratory of Life Sciences and Bioinformatics High School!
A new high school program from the Buffalo City School District will debut this fall with 60 incoming freshman in the former Triangle Academy building in South Buffalo. The school is motivated by the growth of the Buffalo Niagara Medical Campus and the strength of the health-care industry in Western New York, and the eventual goal is to move its 120 upperclassmen to a full-time site somewhere in that medical corridor. Both Empire Genomics -- a growing diagnostics company -- and the University at Buffalo have signed on as partners to help guide curriculum and foster connections in the medical community.
Read More
Does Buffalo have enough biotech workers to fill need?
Experienced industry veterans can be harder to find locally, said Anthony Johnson, president and CEO of Empire Genomics, but he said those workers can be persuaded to move here when they see the energy and growth in the downtown medical corridor.
Read More
Empire Genomics Obtains CE Marking
Empire Genomics has announced that it has received CE Mark designation for a number of its molecular diagnostic products. This is an important designation for the European Economic Area (EEA) and is a demonstration of the company’s commitment to providing the highest level of quality products.
Read More
Empire Genomics is collaborating
Empire Genomics, a Buffalo-based life sciences company that provides clinical services and develops high-tech tests for cancer, is collaborating with Memorial Sloan Kettering Cancer Center in Manhattan and five other hospitals in a partnership meant to standardize how prostate cancer is tested and reported.
Read More
Empire Genomics Announces Agreement with Cancer Centers for the Standardization of Prostate Diagnostics
Empire Genomics, LLC (www.empiregenomics.com), a leading provider of oncology molecular diagnostics products and services, which enable precision medicine has announced a strategic collaboration with Memorial Sloan Kettering Cancer Center (MSK) to support their DOD Transformative Impact Award: Toward the Practice of Precision Medicine: A Biomarker Validation Coordinating Center.
Read More
Empire Genomics Names Dr. John J. Rushton as Chief Operating Officer
Empire Genomics announces today it has appointed Dr. John J. Rushton as Chief Operating Officer. As COO, Dr. Rushton will be responsible for overseeing day-to-day operations and ensuring company alignment with corporate strategies to enhance service delivery to Empire Genomics’ customers worldwide. He brings a wealth of experience having worked at both large and rapidly growing molecular diagnostic firms. He will provide operational, scientific, technical, and leadership support as Empire Genomics expands its footprint and testing options.
Read More
Showcasing Empire Genomics to Steve Case on the Rise of the Rest Tour
Empire Genomics hosted Steve Case and the Revolution Team for the Rise of the Rest Tour at its location in Buffalo, New York on September 30, 2015. Mr. Case discussed with company executives the healthcare innovations taking place at their facility, and how it serves as a driver for economic development in the local community. The company was chosen out of many other worthy firms in the area, and was the only biotech organization toured.
Read More
'Committed to Growing'
Empire Genomics could be located anywhere. Why Buffalo?
Read More
Empire Genomics Strengthens Worldwide Distribution Network
Empire Genomics is pleased to announce its growing network of international distributors which spans twenty-nine companies in twenty-three countries, making available the organization’s offerings - FISH Probes, cell culture media products, and molecular services including Next-Gen Sequencing - to a wider breadth of clients and potential partners across the globe.
Read More
Empire Genomics Raising $15M Venture Capital Round, Seeking New HQ Around Medical Campus
Empire Genomics is raising a $15 million round of venture capital - one that will likely include the local investors that have previously backed the company – and expects to close it in the last three months of this year.
Read More
Empire Genomics Chosen by First Niagara for the 2015 Sponsor's Award at Amherst Chamber SBA Showcase
“First Niagara congratulates Empire Genomics on being named Small Business of the Year,” said Trina Burruss, First Niagara Branch Manager. “We celebrate their success and are proud to support the innovative work they are doing to personalize medical treatment.”
Read More
Empire Genomics Unveils Signature Fellowship Training Program
The promise of personalized medicine will only be realized with smart, passionate, and experienced people to help shape the industry’s development. Empire Genomics, through its’ Fellowship Program, seeks to bridge the gap between academic theory and industry application.
Read More
Norma Nowak named Executive Director of UB's New York State Center of Excellence in Bioinformatics and Life Sciences
Norma Jean Nowak, PhD, a renowned research scientist, educator, collaborator and entrepreneur, has been named executive director of the University at Buffalo’s New York State Center of Excellence in Bioinformatics and Life Sciences (CBLS).
Read More
Empire Genomics Acquires ID Labs, Inc. A Leading Molecular Diagnostic Reagent Company
Empire Genomics today announced the acquisition of ID Labs, Inc., a leading molecular diagnostic reagent company operating out of London Ontario. ID Labs has been providing high quality products for well over 20 years and has strong distribution and customer relationships globally.
Read More
Empire Genomics Partners with Quadpharma to Manufacture ASRs
Empire Genomics, LLC, (www.empiregenomics.com), a leading molecular diagnostics company in the field of personalized cancer medicine, and QuaDPharma, (www.qdpharma.com), a rapidly growing commercial contract manufacturer, announced the completion of the first batch of GMP manufactured products.
Read More
Empire Genomics Partner in New York Genome Center-University at Buffalo Project
"Building out our ability to take large-scale sequencing data will allow us to sift through that data and create assays that companies like Empire and Lineage will use to build the suite they’re putting out there," said Norma Nowak, founder and chief scientific officer of Empire Genomics and a professor in UB’s School of Medicine and BioMedical Sciences.
Read More
Empire Genomics Advances to Semi-Finals in Global Business Competition
"By attracting talented entrepreneur and promising businesses to Buffalo, the 43North business competition is helping to bring new life into the economy in Western New York. This competition is all about bringing the most innovative start-up ventures from around the globe to Buffalo, where they can tap into a world-class workforce and unparalleled environment to thrive for years to come," said Governor Cuomo.
Read More
Rand Partners With Innovate NY Fund to Invest in Personalized Cancer Medicine Business, Empire Genomics, LLC
Empire Genomics has proprietary assays for prostate and multiple myeloma, with expertise in employing genomic technologies to improve clinical outcomes. Its customers include many well-known hospitals, pharmaceutical clients and academic centers. These funds will be used to accelerate the pace of growth through acquiring new technologies, growing staff and increase its test offerings.
Read More
USCAP 2014 | March 1-7 | San Diego, CA | Booth# 1024
Empire Genomics is proud to be exhibiting at the upcoming USCAP 2014 Annual Meeting in San Diego, California, March 1-7.
Read More
Dr. Norma Nowak Speaks At West Seneca Life Sciences Academy Induction Ceremony
The iSciWNY workforce development program, created by the University at Buffalo's New York Center for Excellence in Bioinformatics and Life Sciences and Educational Opportunity Center (EOC), has collaborated with the West Seneca Central School District to create a first-of-its-kind academy that links high school students with potential employers in Western New York's growing life sciences industry.

The new academy will help fill a regional gap in pre-college preparation in STEM (science, technology, engineering, mathematics). Through classroom-based activities and internships, it aims to provide high school students with the practical skills they need to pursue careers in the life sciences industry, and create an educated workforce for area employers.
Read More
CSO & Founder Dr. Norma Nowak delivers her inspirational lecture 'Why Not You?' at Tedx Buffalo Women
Norma Nowak, the Founder and CSO of Empire Genomics, speaks at TEDxBuffaloWomen.
Read More
More Economic Activity In Store For Buffalo from Genomics Project
The research accelerated by the two projects "could really revolutionize health care here in Western New York and across our entire state," said Anthony Johnson, Empire Genomics' President and CEO.
Read More
Empire Genomics to benefit from Governor Cuomo's public-private partnership program to make NYS a Genomics Research Leader
Four companies will be the initial beneficiaries of the collaboration, according to UB and state officials. They are Computer Task Group, a Buffalo-based information technology solutions firm; Empire Genomics, which arose out of research at Roswell Park; AESKU Diagnostics, a German-based life sciences firm seeking to establish a new operation in the Buffalo area and Lineagen, a Salt Lake City, Utah-based firm seeking to expand its medical diagnostics business.
Read More
New York State Department of Health Issues Clinical Laboratory Permit to Empire Genomics
Buffalo, New York - Empire Genomics, LLC (www.empiregenomics.com), an emerging molecular diagnostics company in the field of personalized medicine, announced today that its clinical laboratory facility has met the rigorous standards and obtained approval by the New York State Department of Health, and is now fully licensed (#PFI 8680) in Cytogenetics-Cancer. Simultaneously, Empire Genomics’ lab received Clinical Laboratory Improvements Amendments (CLIA) certification of registration (#33D2043745) from the Centers for Medicare and Medicaid Services (CMS).
Read More
Empire Genomics and QuaDPharma Join Forces for Cancer Research Fundraiser
The President and CEOs of Empire Genomics, LLC, a global molecular diagnostics company in the field of oncology, and QuaDPharma, a rapidly growing small-to-medium scale commercial contract manufacturer, will consort to host a Halloween happy hour (5-8pm) to raise funds on October 30, 2013 for bile duct cancer research and The Jacquie Hirsch for A.L.L. (acute lymphocytic leukemia ) Foundation.
Read More
Subtype of Highly Aggressive Prostate Cancer Increasing; Tied to Drug Resistance to Hormone Therapy
Currently there is a Catch-22 occurring in advanced prostate cancer treatment. Newly FDA-approved, highly potent, anti-androgen medications used to treat advanced prostate cancer have improved survival time in men with treatment-resistant prostate cancer; however, those very drugs may be inducing some men’s cancer to further evolve into a subtype of cancer called neuroendocrine prostate cancer that is highly lethal.
Read More
Another Voice: Buffalo has its visionaries, but we don't follow them
We have many visionaries in Buffalo, such as Jordan Levy, Norma Nowak, Dr. Nick Hopkins and Dr. Donald Trump. The problem is that, unlike Albany, our region hasn’t embraced their visionary ideas. If Buffalo doesn’t tear down the wall of resistance to change, then the New York billion will go nowhere but down the drain. Next time we have a major project to undertake, we should ask ourselves: Would Alain Kaloyeros do it this way? We have visionaries with ideas. Now let’s use them.
Read More
Patent ruling won't alter Empire Genomics approach
A Buffalo biotech firm says the U.S. Supreme Court decision this week on patents and genetics won't likely have a major impact on its business, but the ruling does provide some clarity. Thursday’s Supreme Court decision involved patents by Salt Lake City-based Myriad Genetics Inc., which holds patents related to the discovery and sequence of two genes, which it used to develop tests for breast and ovarian cancer. Simply put: The court said naturally-occurring human genes cannot be patented.
Read More
UB, Empire Genomics partner with Life Technologies to accelerate innovative, genetics-based clinical research in Western New York
Empire Genomics, Life Technologies Corporation and the University at Buffalo will embark on a new partnership to develop world-class gene sequencing facilities for genetics-based clinical research on the Buffalo Niagara Medical Campus. The collaboration capitalizes on each organization’s strengths to help establish a new standard for genomic research in Western New York and continue to grow the life sciences sector of the region’s economy.
Read More
Empire Genomics Awarded SBIR Phase I Grant from NCI for Companion Diagnostics for Multiple Myeloma
Empire Genomics, LLC (www.empiregenomics.com) has been awarded a Phase I SBIR Grant by the National Institute of Health/National Cancer Institute to develop a genomic companion diagnostic test for multiple myeloma (MM). This is the first SBIR grant Empire Genomics has been awarded and it will be funded through October 2013. The Company plans to use these funds to further develop its licensed technology to investigate methods in genomics to predict MM patient response to therapeutic treatments.
Read More
Empire Genomics Licenses Novel DNA Biomarker for Use in Diagnosing and Creating a Companion Diagnostic Test for Neuroendocrine Prostate Cancer
Empire Genomics announced today it has acquired an exclusive license for a patent pending novel genomic biomarker from Cornell University for use in developing a molecular diagnostic test that could help in diagnosing and determining treatment for patients with neuroendocrine (NEPC) prostate cancer.
Read More
Buffalo has a presence at major Chicago event
A contingent including representatives from 12 area life-sciences companies and the major institutions on the Buffalo Niagara Medical Campus is in Chicago this week for the BIO International Convention. Local convention attendees include representatives Empire Genomics.
Read More
Use state's billion for start-ups
Norma Jean Nowak knows firsthand how hard it can be to turn a scientific breakthrough into a profitable business – and she hopes the programs that are part of Gov. Andrew Cuomo’s promised “Buffalo Billion” will make the path a little easier for those who follow. The goal, she said, is to create a village within the Buffalo Niagara region where startups can easily get the management and business development support they need, along with access to the capital that’s so essential to survival in the days before the sales start rolling in.
Read More
Empire Genomics Licenses First Known DNA Biomarker for Use in Determining Drug Response in Multiple Myeloma and Potentially Lymphoma Patients
Empire Genomics announced today it has acquired an exclusive license for patent pending novel genomic biomarkers from Emory University for use in developing a molecular diagnostic test that could help satisfy a large unmet medical need in determining ideal therapeutic treatment for multiple myeloma patients.
Read More
The Jobs of Buffalo's Future Growing
Gone are the days of 12 hour shifts milling flour in what was once the world's largest flour mill or sweating in the queen city's massive iron and steel factories. buffalo's coveted labor jobs of the forties and fifties have now been at least partly replaced by hi-tech and high paying jobs in the medical sciences and research fields.
Read More
Diagnostics company develops cancer test

Empire Genomics LLC announced Nov. 1 that it will begin development of a new cancer test it said will help physicians select the right drug therapies based on the individual patients’ genetic markers.


The diagnostics company, based on the Buffalo Niagara Medical Campus, said the test will be the first proprietary therapeutic guiding test on the market to deliver precise treatment options for oncology patients with multiple myeloma and lymphoma, while bringing the company closer to delivering personalized medicines.

Read More
Empire Genomics plans to expand
A company that develops tests to pinpoint whether a specific medical drug or treatment will help an individual patient announced Thursday plans to hire 50 new employees over the next five years at its offices on the edge of the Buffalo Niagara Medical Campus.

Empire Genomics will hire the workers to conduct, manufacture and market a new test meant to determine the best form of treatment for multiple myeloma, a blood-based cancer.
Read More
Buffalo company develops cancer test
The evolution of Buffalo's medical corridor is paving the way for healthier lives as a new procedure developed in western New York adds more firepower to the war on cancer. Empire Genomics on Michigan Avenue has developed the very first test for multiple myeloma. This procedure can help determine the treatment of malignant blood cell cancer. The new test will also create about 50-new jobs over the next few years.
Read More
Empire Genomics Unveils New Multiple Myeloma Molecular Cancer Test and New Clinical Laboratory
Empire Genomics, a growing cancer molecular diagnostics company, today unveiled the first ever multiple myeloma cancer test and its plans to hire 50 new employees over the next five years. Empire Genomics, a growing cancer molecular diagnostics company founded in Buffalo in 2006, today unveiled the first ever multiple myeloma cancer test.
Read More
12 Western New York and 3 Ontario, Canada Companies Selected to Present in Statewide Venture Forum
Empire Genomics has been chosen to present for the 2012 Venture Forum, a collaboration between the Bright Buffalo Niagara Forum and the Center for Economic Growth's (CEG) SmartStart UNYTECH Forum
Read More
UB Partnerships Allow Empire Genomics to Flourish
Local life sciences start-up Empire Genomics has gone global thanks to a partnership with the University at Buffalo. The firm has grown the business from a concept to product to a company with rapidly growing revenues and a significant global customer base.
Read More
Empire Genomics Names Funakoshi its Japan Distributor
Empire Genomics today announced Funakoshi will distribute its products in Japan.
Read More
Congresswoman Kathy Hochul Visits Empire Genomics
Before hosting an Economic Action Summit for Western New York, Congresswoman Kathy Hochul visited Empire Genomics along with a number of other major economic stakeholders in the region.
Read More
As life sciences sector grows, so does the need for capital
Empire Genomics has nine employees, including Johnson, who since the beginning in 2006 has been CEO of the company, which is located on Michigan Avenue in the Western New York Medical Arts Building on the medical campus. The company hopes to open a clinical lab so that it can begin processing patient samples and giving disease diagnoses itself. Empire Genomics hopes to hire five to 10 employees for this clinical lab and the company’s clinical trial partnerships.
Read More
Empire Genomics, Icon Team on Personalized Medicine Services
NEW YORK (GenomeWeb News) - Irish drug development services firm Icon said this week that it has signed an agreement with Empire Genomics to provide personalized medicine development services.
Read More
Lower Cost and Faster Product Approval Through Proper Software Design Controls
The market success of a medical device depends in large part on how well its software is programmed. Focusing heavily on the device while treating the software as an afterthought can lead to costly recalls and liability concerns.
Read More
Funds flow to WNY expansion projects
Empire State Development announced that seven Western New York companies have been awarded $5.75 million in loans and grants to assist with various expansion projects. The state’s top economic development agency said collectively, these companies, operating in Cattaraugus, Erie and Niagara counties, will make capital investments totaling $112.6 million, retaining 1,785 jobs and creating 329 full-time jobs.
Read More
Testing your own personal genome - opening a Pandora's Box?
Anthony Johnson, President & CEO of Empire Genomics discusses personal genomic testing and the necessary precautions that must be put in place before this technology can effectively be used as an informative tool for patients interested in having these tests performed.
Read More
One Cell Systems and Empire Genomics Initiate DNA Probe Product Development and Distribution Agreement
One Cell and Empire Genomics come together to offer 24 Chromosome/24 Hour PGD FISH Panel to launch in January 2009 along with other high quality products and services to follow.
Read More
Good Morning America Co-Anchor receives Gilda Radner Courage Award from Roswell Park Cancer Institute
Robin Roberts, co-anchor of ABC's Good Morning America and a breast cancer survivor received the Gilda Radner Courage Award tonight at Roswell Park Cancer Institute's All Star Night gala. Roberts has served as a highly visible advocate for breast cancer screening and early detection since being diagnosed with the disease in 2007.
Read More
Empire Genomics Names Leading Genetic Researchers and Industry Experts to Scientific Advisory Board
Empire Genomics, developing high throughput technologies that enable genome-wide analyses to determine the underlying mechanisms for diseases, today announced the formation of its Scientific Advisory Board.
Read More
Dr. Norma Nowak- AACR 2008 Team Science Award Winner
Empire Genomics Founder Dr. Norma Nowak, along with 11 other experts in the field, have been honored for their active roles in the conception, technical implementation, dissemination and pioneering applications of comparative genomic hybridization (CGH) and array CGH.
Read More
Michael J. Becich, M.D., Ph.D. Joins Empire Genomics Scientific Advisory Board
Empire Genomics, a leader in the field of genomic molecular diagnostics and personalized medicine, is pleased to announce the appointment of Michael J. Becich, M.D., Ph.D., to its Scientific Advisory Board. Dr. Becich is a leading expert on cancer biology and biomedical informatics.

"We are excited to welcome Dr. Becich to our SAB," commented Anthony Johnson, President/CEO of Empire Genomics. "He has tremendous knowledge in cancer biology and informatics, both of which are critical aspects of our corporate objectives in personalized medicine. We look forward to working with Dr. Becich to continually innovate and translate cutting edge research into clinical molecular testing solutions."
Read More
Empire Genomics Sponsors The Belle Center Golf Classic
Empire Genomics will be sponsoring the second annual Belle Center Golf Classic on July 23rd, 2012 from 11AM to 7:30PM at The Orchard Park Country Club located in Orchard Park New York. Proceeds from The Belle Center Golf Classic benefit youth and families who utilize programs and services at The Belle Center.
Read More
12 Western New York and 3 Ontario, Canada Companies Selected to Present in Statewide Venture Forum
The final slate of presenting companies has been chosen for the 2012 Venture Forum, a collaboration between the Bright Buffalo Niagara Forum and the Center for Economic Growth's (CEG) SmartStart UNYTECH Forum.

A total of 32 high-growth early stage companies will be featured, including 12 from Buffalo and three from Ontario, Canada. The 2012 Venture Forum will be held May 16-17 in Buffalo. Since its inception three years ago, the Bright Forum has featured nearly 100 high-tech companies.
Read More
UB Partnerships Allow Empire Genomics to Flourish
Local life sciences start-up Empire Genomics has gone global thanks to a partnership with the University at Buffalo. The firm has grown the business from a concept to product to a company with rapidly growing revenues and a significant global customer base.

At a time when state and local officials are hoping to lure new companies to the Buffalo Niagara region, stories like Empire Genomics' are key to understanding the value of collaborations between industry and academia. University entities such as UB's New York State Center of Excellence in Bioinformatics and Life Sciences and the UB Center for Advanced Biomedical and Bioengineering Technology (UB CAT) help to facilitate these connections in the life sciences.
Read More
Patent: Methods of combined bioprocessing and related microorganisms, thermophilic and/or acidophilic enzymes, and nucleic acids encoding said enzymes
A genetically modified organism comprising: at least one nucleic acid sequence and/or at least one recombinant nucleic acid isolated from Alicyclobacillus acidocaldarius and encoding a polypeptide involved in at least partially degrading, cleaving, transporting, metabolizing, or removing polysaccharides, cellulose, lignocellulose, hemicellulose, lignin, starch, sugars, sugar oligomers, carbohydrates, complex carbohydrates, chitin, heteroxylans, glycosides, xylan-, glucan-, galactan, or mannan-decorating groups; and at least one nucleic acid sequence and/or at least one recombinant nucleic acid encoding a polypeptide involved in fermenting sugar molecules to a product.
Read More